XTAEAYAL
Market cap226mUSD
Dec 24, Last price
3,300.00ILS
1D
1.63%
1Q
59.65%
Jan 2017
-4.46%
Name
Ayalon Insurance Company Ltd
Chart & Performance
Profile
Ayalon Insurance Company Ltd, through its subsidiaries, provides various insurance products in Israel. It offers health insurance products, including nursing, medical expenses, surgeries and transplants, dental, personal accident, travel, and medical insurance for foreign workers; house certificates; and third party and employer, property, vehicle, and professional liability insurance products. The company also provides savings, pension, and provident fund products. In addition, it offers car, home, critical illness, life, mortgage, business, directors and officers, engineering, and agricultural insurance products, as well as reverse mortgages, and insurance products for collectives and organizations. The company serves its customers through a network of agents and agencies. Ayalon Insurance Company Ltd was formerly known as Ayalon Holdings Ltd and changed its name to Ayalon Insurance Company Ltd in July 2022. The company was founded in 1976 and is based in Ramat Gan, Israel. Ayalon Insurance Company Ltd is a subsidiary of Wesure Global Tech Ltd.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 3,426,939 50.88% | 2,271,289 -27.83% | 3,147,149 28.17% | |||||||
Cost of revenue | 305,465 | 47,450 | 49,754 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 3,121,474 | 2,223,839 | 3,097,395 | |||||||
NOPBT Margin | 91.09% | 97.91% | 98.42% | |||||||
Operating Taxes | 35,893 | 31,287 | 5,176 | |||||||
Tax Rate | 1.15% | 1.41% | 0.17% | |||||||
NOPAT | 3,085,581 | 2,192,552 | 3,092,219 | |||||||
Net income | 73,037 -58.43% | 175,714 -254.11% | (114,022) 77.45% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 6,055 | 5,305 | ||||||||
Long-term debt | 697,078 | 759,492 | 827,854 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 14,538,893 | (354,819) | (882,134) | |||||||
Net debt | 287,009 | (10,663,726) | (11,190,679) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (65,058) | 335,351 | (306,023) | |||||||
CAPEX | (4,993) | (107,541) | (83,190) | |||||||
Cash from investing activities | (104,224) | (5,436) | (82,545) | |||||||
Cash from financing activities | (8,965) | (66,421) | 143,916 | |||||||
FCF | 3,092,212 | 2,193,397 | 3,087,814 | |||||||
Balance | ||||||||||
Cash | 410,069 | 3,227,510 | 3,082,806 | |||||||
Long term investments | 8,201,763 | 8,941,032 | ||||||||
Excess cash | 238,722 | 11,315,709 | 11,866,481 | |||||||
Stockholders' equity | 705,170 | 636,001 | 453,200 | |||||||
Invested Capital | 15,702,419 | 14,868,615 | 15,191,649 | |||||||
ROIC | 20.19% | 14.59% | 21.42% | |||||||
ROCE | 19.58% | 14.27% | 19.69% | |||||||
EV | ||||||||||
Common stock shares outstanding | 21,537 | 18,198 | 18,198 | |||||||
Price | 16.14 23.77% | 13.04 -49.67% | 25.91 41.97% | |||||||
Market cap | 347,607 46.48% | 237,302 -49.67% | 471,510 41.97% | |||||||
EV | 636,295 | (10,424,776) | (10,717,559) | |||||||
EBITDA | 3,200,967 | 2,299,746 | 3,164,939 | |||||||
EV/EBITDA | 0.20 | |||||||||
Interest | 36,595 | 42,748 | ||||||||
Interest/NOPBT | 1.65% | 1.38% |